Andrea Necchi, Joep Jacobus de Jong, James A. Proudfoot, Chiara Mercinelli, Brigida Anna Maiorano, Antonio Cigliola, Valentina Tateo, Michela Piacentini, Enrico Tomasi, Elai Davicioni, Marco Moschini, Giorgio Brembilla, Maurizio Colecchia, Francesco De Cobelli, Alberto Briganti, Jeffrey S. Ross, Dean C. Pavlick, Francesco Montorsi. "Neoadjuvant sacituzumab govitecan (SG) plus pembrolizumab (Pembro), followed by response-adapted bladder sparing and adjuvant pembro, in patients with muscle-invasive bladder cancer (MIBC): SURE-02 primary analysis and biomarker results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.769